Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease. | Orphanet J Rare Dis | 2024 | 38671465 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals the Wnt/Ca2+ signaling pathway with inflammation, apoptosis in nucleus pulposus degeneration. | BMC Musculoskelet Disord | 2024 | 38654287 | PubTator, text mining | PubMed |
| El diálogo oculto entre el hueso y los tejidos a través del remodelado óseo. | Adv Lab Med | 2024 | 38634083 | PubTator, text mining | PubMed |
| Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass. | Osteoporos Int | 2024 | 38625381 | PubTator, text mining | PubMed |
| LDL receptor-related protein 5 selectively transports unesterified polyunsaturated fatty acids to intracellular compartments. | Nat Commun | 2024 | 38594269 | PubTator, text mining | PubMed |
| 17 variants interaction of Wnt/β-catenin pathway associated with development of osteonecrosis of femoral head in Chinese Han population. | Sci Rep | 2024 | 38538713 | PubTator, text mining | PubMed |
| Low-density lipoprotein receptor-related protein 5/6 promotes endometrial cancer progression and cancer cell immune escape. | J Biochem Mol Toxicol | 2024 | 38528715 | PubTator, text mining | PubMed |
| Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications. | NPJ Precis Oncol | 2024 | 38438481 | PubTator, text mining | PubMed |
| Severe Osteoporosis With Pathogenic LRP5 Variant. | JCEM Case Rep | 2024 | 38404691 | PubTator, text mining | PubMed |
| Effects of Fc glycosylation on the activity of WNT mimetic agonistic antibodies. | Antib Ther | 2024 | 38371954 | PubTator, text mining | PubMed |
| Deciphering a crucial dimeric interface governing Norrin dimerization and the pathogenesis of familial exudative vitreoretinopathy. | FASEB J | 2024 | 38363575 | PubTator, text mining | PubMed |
| Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination. | Genome Med | 2024 | 38321573 | PubTator, text mining | PubMed |
| Gene variants for the WNT pathway are associated with severity in periodontal disease. | Clin Oral Investig | 2024 | 38319382 | PubTator, text mining | PubMed |
| TMEM16A inhibits renal tubulointerstitial fibrosis via Wnt/β-catenin signaling during hypertension nephropathy. | Cell Signal | 2024 | 38316267 | PubTator, text mining | PubMed |
| Relationship between polymorphisms and mutations at rs7125942 and rs3736228 of LRP5 gene and bone metabolism in postmenopausal women. | J Orthop Surg Res | 2024 | 38302983 | PubTator, text mining | PubMed |
| Effectiveness of romosozumab in primary biliary cholangitis at half the recommended dose in an underweight patient. | Bone Rep | 2024 | 38298922 | PubTator, text mining | PubMed |
| Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage. | PLoS One | 2024 | 38295140 | PubTator, text mining | PubMed |
| Osteopetrosis complicated by multilevel spondylolysis. | Radiol Case Rep | 2024 | 38292800 | PubTator, text mining | PubMed |
| The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | 38292186 | PubTator, text mining | PubMed |
| Molecular landscape of congenital vertebral malformations: recent discoveries and future directions. | Orphanet J Rare Dis | 2024 | 38291488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=9